Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2000-03-24
2002-03-12
Mertz, Prema (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007210, C435S007230
Reexamination Certificate
active
06355446
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to the retinoid X receptor, referred to hereafter as “RXR.” More particularly, it relates to the identification of its ligands, and the ramifications of this identification.
BACKGROUND AND PRIOR ART
The nuclear receptor (NR) superfamily comprises more than 150 different proteins, most of which are believed to function as ligand activated transcription factors, exerting widely different biological responses by regulating gene expression (for review, see Di Croce et al, EMBO J1 8:6201-6210 (1999); Mangelsdorf, et al Cell 83:825-839 (1995); Perlmann, et al, Cell 90:391-397 (1997)). Members of this family include receptors for endogenous small, lipophilic molecules, such as steroid hormones, retinoids, vitamin D and thyroid hormone. In addition, many members of this family lack known ligands and are therefore referred to as “orphan receptors” (for review, see Gigère, et al, Endocrine Rev 20:689-725 (1999); Kastner, et al, Cell 83:859-869 (1995)).
During recent years small, lipophilic ligands and activators have been identified for several orphan receptors, leading to new insights of profound impact. These findings have dramatically increased understanding of endocrinology and disease (Forman, et al Cell 81:687-693 (1997); Xu, et al, Mol. Cell 3:397-403 (1999); Makashima et al., Science 284:1362-1365 (1999); Parks et al., Science 284:1365-1368 (1999); Wang et al., Mol Cell 3:543-553 (1999); Janowski et al., Nature 383:728-731 (1996); Kliewer et al., Cell 92:73-82 (1998); Blumberg et al., Genes Dev. 12:31953205 (1998)); however, ligands and biological functions of most orphan receptors remain to be elucidated, emphasizing the importance of unraveling previously uncharacterized signaling pathways by identifying novel endogenous ligands for NRs (for review, see Mangelsdorf et al, Cell 83:841-850 (1995); Giguère, et al, supra.
The retinoid X receptor (RXR) is activated by the vitamin A metabolite 9-cis retinoic acid, which binds with high affinity to the RXR ligand binding domain. In addition, RXR has been shown to form heterodimers with a large number of NRs including the retinoic acid receptor (RAR) and several orphan receptors. RXRs are essential for development of the embryo as shown by gene ablation experiments. In addition, genetic analyses of mutant mice have indicated important functions in the adult, e.g. in the central nervous system.
Dietary fatty acids have long been recognized as essential for normal growth and development, as energy fuels, membrane components and as precursors of essential lipidmetabolites (Salem et al., In Health Effects of Polyunsaturated Fatty Acids in Seafoods (1986); Neuringer et al., Ann Rev Nutr 8:517-541 (1998); Horrocks et al, Pharmacological Res 40:211-225 (1999); Xiang and Zetterstrom, Acta Paediatr 88:78-82 (1999)). Fatty acids are classified as “non-essential” and “essential,” respectively. Essentially fatty acids cannot be synthesized in humans and must be taken up via the diet. These include linoleic acid (18:2n−6), alpha-linolenic acid (18:3n−3), and their elongation and desaturation products arachidonic acid (20:4n−6) and docosahexaenoic acid (DHA; 22:6n−3), respectively (for a description of fatty acid nomenclature, see e.g. Neuringer et al., supra. Arachidonic acid has been shown to be the major precursor of eicosanoids, a large family of biologically active factors including prostaglandins, prostacyclins, leukotrienes and hydroxy fatty acids. These metabolites act as chemical transmitters both within and between cells, and have been shown to regulate ion transport, hormone secretion and the immune response. Interestingly, several arachidonic acid metabolites and other fatty acids have been shown to function as ligands for peroxisomeproliferator activated receptors, demonstrating that they can function as mediators of NR signaling cascades, in vivo.
In contrast to arachidonic acid metabolites, the mechanism(s) of action of DHA is not well understood. Interestingly, DHA accumulates at high levels in the postnatal mammalian CNS indicating that DHA is involved in the maturation of the CNS and/or in neurological processes. Notably, DNA deficiencies lead to neurological abnormalities and diminished learning ability in man (see Gamoh, et al, Neurosci 93:237-241 (1999); Fernstrom, Lipids 34:161-169 (1999); Sheaff Greiner, et al, Lipids Suppl 34:239-243 (1999)). Moreover, dietary DHA may be beneficial in treatment of atherosclerosis, inflammation and cancer (Horrocks, et al, Pharmacol Res 40:211-225 (1999); Rose, et al, Pharmacol Theraput 83:217-244 (1999)).
It has now been ascertained that DHA functions as a ligand for RXRs. As is elucidated herein, DHA may exert its biological activities, in whole or in part, by way of activating RXRs. This pathway has not been described in the prior art, and is a feature of the invention, as will be elucidated herein.
REFERENCES:
patent: 5399586 (1995-03-01), Davies et al.
patent: 5747661 (1998-05-01), Evans et al.
patent: 5766571 (1998-06-01), Ceriani et al.
patent: 5854292 (1998-12-01), Ailhaud et al.
patent: 5925669 (1999-07-01), Katz et al.
patent: 5972881 (1999-10-01), Heyman et al.
I. Issemann et al.; The peroxisome proliferator-activated recetor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs ; 1993; pp. 47.*
Haisu Wan et al.; Overexpressed Activated Retinoid X Receptors Can Mediate Growth Inhibitory Effects of Retinoids in Human Carcinoma Cells; Oct. 9, 1998, pp. 26915-26922.*
Balkan, et al., “Transgenic indicator mice studying activated retinoic acid receptors during development,”Proc. Natl. Acad. Sci. USA 89: 3347-3351 (Apr. 1992).
Lemon, et al., “Selective Effects of Ligands On Vitamin D3Receptor and Retinol X Activation In Vivo,”Mol & Cell Biol 16(3):1006-1016 (March 1996).
Wang, et al., “Ligand-Inducible and Liveer—Specific target gene expression in transgenic mice,”Nature Biotechnol 15: 239-243 (March 1997).
Solomin, et al., “Retinol-X Receptor Signaling In The Developing Spinal Cord,”Nature 395: 398-402 (Sep. 1998).
de Urquiza Alexander Mata
Griffiths William
Perlmann Thomas
Sjöberg Maria
Sjövall Jan
Fulbright & Jaworski LLP
Ludwig Institute for Cancer Research
Mertz Prema
Murphy Joseph F.
LandOfFree
DocosahexAenoic acid as retinoid X-receptor ligand and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DocosahexAenoic acid as retinoid X-receptor ligand and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DocosahexAenoic acid as retinoid X-receptor ligand and uses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2884880